Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Elite athletes test if eating carbs last keeps blood sugar steadier

NCT ID NCT07247513

Knowledge-focused Sponsor: Universidade do Porto Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether eating the fast-digesting carbs at the end of a meal (instead of at the start) changes blood sugar levels in 22 elite female athletes. Over 6 days, participants wore a continuous glucose monitor and followed different meal sequences for breakfast and supper. The goal was to see if meal order could help manage blood sugar spikes during training and rest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

22 people

The number who actually took part.

Started

Nov 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 64 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult (18-64 years old) * Women * Elite athletes (meeting training and performance caliber criteria ≥Tier 4; McKay et al., 2022) * Healthy (meeting the exclusion criteria for medical conditions) * Normal glucose tolerant according to the latest review standards of the American Diabetes Association (ElSayed et al., 2024): HbA1c \<5.7%, fasting plasma glucose \<5.6 mmol/L (100 mg/dL), or 2-h plasma glucose \<7.8 mmol/L (140 mg/dL) during a 75-g OGTT * Able and willing to provide informed consent and safely comply with study procedures Exclusion Criteria: * Any medical condition or behaviour deemed either to pose undue personal risk to the participant or introduce bias into the experiment (e.g. pregnancy, alcohol or substance abuse; any condition affecting the glucose and lipid metabolism or appetite, reviewed on a case by case basis) * Any reported medication or supplementation that may interfere with the glucose metabolism (e.g., acarbose, aspirin, berberine, insulin, metformin, semaglutide, sulfonylureas, thiazide diuretics, thiazolidinediones, vitamin C). Other medication and supplementation will be reviewed on a case by case basis. * Recent change in body mass (± 2 kg in the last 2 months) * Smoking

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dietary intervention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity nutritional disorder sleep disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dietary intervention Exercise Glycemic variability Healthy Nutrition Sleep

Contacts and locations

Locations

  • Cidade do Futebol

    Oeiras, Lisbon District, 1495-433, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.